Helping people with colorectal cancer understand genomic testing and participation
Engagement Optimization Unit
The team will create and test clearer ways to explain genomic testing, consent, and results so people with colorectal cancer can more easily join and stay in genomics programs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11192767 on NIH RePORTER |
What this research studies
You would be invited to help shape clearer materials and ways to talk about genomic testing for colorectal cancer. The project works with people who have metastatic and non-metastatic CRC to try different communication methods, educational tools, and consent approaches and then asks for feedback on which ones are most useful. The team will refine those methods through repeated testing and use the results to build a participant-centered toolkit for clinicians and research staff. The toolkit is meant to make it easier to understand results, decide about participation, and stay engaged over time.
Who could benefit from this research
Good fit: Adults with colorectal cancer (metastatic or non-metastatic) who are willing to review and provide feedback on communication, consent, and result-reporting materials.
Not a fit: People without colorectal cancer, or those not interested in genomic testing or giving feedback on educational materials, are unlikely to see direct benefit.
Why it matters
Potential benefit: If successful, patients could receive clearer information and better support when considering genomic testing, making it easier to enroll and remain involved.
How similar studies have performed: Some prior patient-engagement and plain-language communication efforts have improved understanding and recruitment, but tailored tools for genomic results in diverse colorectal cancer groups are still relatively new.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Baezconde-Garbanati, Lourdes a. — University of Southern California
- Study coordinator: Baezconde-Garbanati, Lourdes a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.